Literature DB >> 24958577

Response--dose ratio is a surrogate of cumulative provocative dosage for bronchial provocation tests in asthma.

Wei-Jie Guan1, Jin-Ping Zheng, Xu Shi, Yan-Qing Xie, Cai-Yu Jiang, Yi Gao, Zheng Zhu, Jia-Ying An, Xin-Xin Yu, Wen-Ting Liu.   

Abstract

BACKGROUND: Response-dose ratio (RDR) and cumulative provocative dosage (PD) are useful indices reflecting airway responsiveness in asthma.
OBJECTIVES: To compare the diagnostic value of RDR and PD, by conducting leukotriene D4 (LTD4-BPT) and methacholine bronchial provocation test (MCh-BPT), in different asthma control levels.
METHODS: Healthy subjects and asthmatic patients underwent LTD4-BPT and MCh-BPT, at 2-14-day interval. This entailed assessment of the distribution characteristics, correlation, and diagnostic value of PD inducing 20% fall in forced expiratory volume in one second (PD20FEV1) and the RDR, defined as FEV1 fall (%) at the final step divided by the corresponding provocative dosage.
RESULTS: Twenty uncontrolled, 22 partly controlled, 20 controlled asthmatics, and 21 healthy subjects were enrolled. Log10RDR was positively correlated with log10PD20FEV1 in both BPTs (all P < 0.05). Poorer asthma control was associated with significantly lower PD20FEV1 and higher RDR (both P < 0.05). The differences in PD20FEV1 and RDR between partly controlled and controlled asthma were unremarkable (both P > 0.05). Compared with log10PD20FEV1, the log10RDR yielded similar diagnostic values in both BPTs. A lower percentile of RDR (≤ 25th percentile) was associated with higher baseline FEV1 (P < 0.05) and an increased proportion of well-controlled asthmatic patients. The combination of RDR and PD20FEV1 led to an increased diagnostic value compared with either parameter alone.
CONCLUSIONS: RDR is a surrogate of PD20FEV1 for BPTs in asthma. This finding was not modified by different asthma control levels or the types of bronchoprovocants.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24958577     DOI: 10.1007/s00408-014-9612-7

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  13 in total

1.  Normative values of pulmonary function testing in Chinese adults.

Authors:  Jinping Zheng; Nanshan Zhong
Journal:  Chin Med J (Engl)       Date:  2002-01       Impact factor: 2.628

2.  Standardisation of spirometry.

Authors:  M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

3.  Impulse oscillometry for leukotriene D4 inhalation challenge in asthma.

Authors:  Wei Jie Guan; Jin Ping Zheng; Yi Gao; Cai Yu Jiang; Xu Shi; Yan Qing Xie; Qing Xia Liu; Mei Jiang; Jia Ying An; Xin Xin Yu; Wen Ting Liu; Li Ping Zhong; Zhong Ping Wu; Nan Shan Zhong
Journal:  Respir Care       Date:  2013-05-28       Impact factor: 2.258

Review 4.  Leukotrienes in the pathogenesis of asthma.

Authors:  P M O'Byrne
Journal:  Chest       Date:  1997-02       Impact factor: 9.410

5.  Leukotriene D4 inhalation challenge for predicting short-term efficacy of montelukast: a pilot study.

Authors:  Wei-jie Guan; Xu Shi; Jin-ping Zheng; Yi Gao; Cai-yu Jiang; Yan-qing Xie; Qing-Xia Liu; Zheng Zhu; E Guo; Jia-ying An; Xin-xin Yu; Wen-ting Liu; Nan-shan Zhong
Journal:  Clin Respir J       Date:  2014-03-05       Impact factor: 2.570

6.  Leukotriene D4 bronchial provocation test: methodology and diagnostic value.

Authors:  Weijie Guan; Jinping Zheng; Yi Gao; Caiyu Jiang; Jiaying An; Xinxin Yu; Wenting Liu
Journal:  Curr Med Res Opin       Date:  2012-05-03       Impact factor: 2.580

7.  Responsiveness to leukotriene D4 and methacholine for predicting efficacy of montelukast in asthma.

Authors:  Wei-Jie Guan; Jin-Ping Zheng; Yi Gao; Cai-Yu Jiang; Yan-Qing Xie; Xu Shi; Zheng Zhu; Jia-Ying An; Xin-Xin Yu; Wen-Ting Liu; Nan-Shan Zhong
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

8.  Airway responsiveness to hypertonic saline: dose-response slope or PD15?

Authors:  G de Meer; G B Marks; J C de Jongste; B Brunekreef
Journal:  Eur Respir J       Date:  2005-01       Impact factor: 16.671

9.  Leukotriene D4 and methacholine bronchial provocation tests for identifying leukotriene-responsiveness subtypes.

Authors:  Weijie Guan; Jinping Zheng; Yi Gao; Caiyu Jiang; Yanqing Xie; Jiaying An; Xinxin Yu; Wenting Liu; Nanshan Zhong
Journal:  J Allergy Clin Immunol       Date:  2012-10-04       Impact factor: 10.793

10.  Bronchial hyperresponsiveness in an adult population in Helsinki: decreased FEV1 , the main determinant.

Authors:  Maria Juusela; Paula Pallasaho; Seppo Sarna; Päivi Piirilä; Bo Lundbäck; Anssi Sovijärvi
Journal:  Clin Respir J       Date:  2013-03-21       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.